Guest: Gualberto Ruano, MD, PhD

Host: Leslie P. Lundt, MD

One-third of patients suffering from schizophrenia develop diabetes as a direct result of treatment. In the future, we may be able to use pharmacogenomics to determine which antipsychotic would be the safest for any given patient. Is the future here? Dr Ruaño joins host Dr. Leslie Lundt to discuss his recent work in this area.